MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
395.86%
Quick Ratio
382.71%
Cash Ratio
316.97%
Debt to Asset Ratio
34.93%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable, net
    • Equity investments, at fair valu...
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
196,576
255,841
79,381
86,218
Accounts receivable, net
36,246
24,992
29,783
17,983
Inventory
8,156
9,292
9,624
11,818
Other receivables
506
516
158
142
Prepaid expenses and other current assets
4,022
4,839
4,895
2,342
Assets held for sale
-
-
0
0
Total current assets
245,506
295,480
123,841
118,503
Property, plant and equipment, net
2,412
2,426
2,519
2,611
Operating lease right-of-use asset, net
11,357
11,822
12,302
12,321
Restricted cash
1,220
1,220
1,220
1,220
Equity investments, at fair value
29,451
18,707
17,660
-
Intangible assets, net
25,510
26,479
27,605
28,670
Other assets
1,259
740
401
18,082
Total assets
316,715
356,874
185,548
181,407
Accounts payable and accrued expenses
49,325
92,986
47,125
45,171
Income taxes payable
5,179
5,418
356
1,005
Common stock warrant liabilities
0
0
1
2
Operating lease liabilities, short-term
2,246
2,221
2,127
2,129
Partner company notes payable, short-term
5,000
2,500
-
5,625
Partner company installment payments - licenses, short-term
-
-
0
0
Other current liabilities
268
268
135
135
Total current liabilities
62,018
103,393
49,744
54,067
Notes payable, long-term
34,602
36,878
52,417
47,774
Operating lease liabilities, long-term
11,468
12,028
12,672
12,765
Partner company redeemable perpetual preferred liability
0
0
7,085
-
Other long-term liabilities
2,541
2,201
1,447
1,616
Total liabilities
110,629
154,500
123,365
116,222
Cumulative redeemable perpetual preferred stock, 0.001 par value, 15,000,000 authorized, 5,000,000 designated series a shares, 3,427,138 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively, liquidation value of 25.00 per share
3
3
3
3
Common stock, 0.001 par value, 200,000,000 shares authorized, 33,311,012 and 31,364,094 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
33
33
31
31
Additional paid-in-capital
788,251
785,851
783,891
785,943
Accumulated deficit
-624,147
-623,679
-734,052
-730,115
Total stockholders' equity attributed to the company
164,140
162,208
49,873
55,862
Non-controlling interests
41,946
40,166
12,310
9,323
Total stockholders' equity
206,086
202,374
62,183
65,185
Total liabilities and stockholders' equity
316,715
356,874
185,548
181,407
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$196,576K (164.26%↑ Y/Y)Accounts receivable, net$36,246K (131.69%↑ Y/Y)Inventory$8,156K (-36.54%↓ Y/Y)Prepaid expenses andother current assets$4,022K (-42.18%↓ Y/Y)Other receivables$506K (-9.32%↓ Y/Y)Total current assets$245,506K (122.39%↑ Y/Y)Equity investments, atfair value$29,451K Intangible assets, net$25,510K (-14.21%↓ Y/Y)Operating leaseright-of-use asset, net$11,357K (-11.39%↓ Y/Y)Property, plant andequipment, net$2,412K (-10.80%↓ Y/Y)Other assets$1,259K (-58.37%↓ Y/Y)Restricted cash$1,220K (0.00%↑ Y/Y)Total assets$316,715K (98.08%↑ Y/Y)Total liabilities andstockholders' equity$316,715K (98.08%↑ Y/Y)Total stockholders'equity$206,086K (451.28%↑ Y/Y)Total liabilities$110,629K (-9.70%↓ Y/Y)Total stockholders'equity attributed to...$164,140K (273.69%↑ Y/Y)Non-controlling interests$41,946K (741.28%↑ Y/Y)Total currentliabilities$62,018K (7.82%↑ Y/Y)Notes payable,long-term$34,602K (-30.83%↓ Y/Y)Operating leaseliabilities, long-term$11,468K (-13.79%↓ Y/Y)Other long-termliabilities$2,541K (52.89%↑ Y/Y)Accumulated deficit-$624,147K (15.19%↑ Y/Y)Additionalpaid-in-capital$788,251K (1.08%↑ Y/Y)Accounts payable andaccrued expenses$49,325K (1.54%↑ Y/Y)Income taxes payable$5,179K (426.32%↑ Y/Y)Partner company notespayable, short-term$5,000K (33.33%↑ Y/Y)Operating leaseliabilities, short-term$2,246K (4.95%↑ Y/Y)Other currentliabilities$268K (-87.06%↓ Y/Y)Common stock, 0.001 parvalue, 200,000,000...$33K (10.00%↑ Y/Y)Cumulative redeemableperpetual preferred...$3K (0.00%↑ Y/Y)

Fortress Biotech, Inc. (FBIO)

Fortress Biotech, Inc. (FBIO)